Home › NDC Lookup › Ingredients › Levmetamfetamine Nasal Decongestant › 00363-0564-53
Vapor Inhaler Levmetamfetamine Nasal Decongestant 50 mg Inhalant — NDC 00363-0564-53 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Vapor Inhaler Levmetamfetamine Nasal Decongestant 50 mg Inhalant — NDC 0363-0564-53 (Billing 00363-0564-53)

by Walgreens · 3 INHALER in 1 BLISTER PACK / 198 INHALANT in 1 INHALER

This is a package of Vapor Inhaler Levmetamfetamine Nasal Decongestant 50 mg Inhalant from Walgreens, marketed since Jul 2016 and currently FDA-listed.

NDC 00363-0564-53
🏷️ FDA NDC (as labeled) 0363-0564-53 billing pads the labeler segment with a zero
This package
Contains198 inhalant in 1 inhaler Pack sizes2 compare ↓
Product page 00363-0564-50 Also comes in: 1 inhaler 0363-0564-50
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0363-0564-53 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0363 labeler · 0564 product · 53 package
Package marketed since
Jul 1, 2016
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0311917178585
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0363-0564-53
Product NDC 0363-0564
11-digit billing NDC 00363056453
UNII Y24T9BT2Q2
UPC 0311917178585
Application # M012
SPL Set ID 77924474-ccc7-497b-9168-91490bcfadfc
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-07-01
Route NASAL
Dosage form INHALANT
Substance LEVMETAMFETAMINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43401000002400
GPI class Decongestant Vapor
GCN Seq No 063018
GCN 98778
HICL code 034953
Ingredient (HICL) Levmetamfetamine
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q7
Therapeutic class — intermediate (HIC2) Nasal Preparations
HIC3 code Q7D
Therapeutic class — specific (HIC3) Nose Preparations, Vasoconstrictors(Otc)
AHFS code 52:32.00.00
AHFS class Vasoconstrictors
FDB label name VAPOR INHALER
FDB brand name Vapor Inhaler
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 063018
  • GCN: 98778
  • GPI-14 (Medi-Span): 43401000002400
  • HICL (First Databank): 034953
  • AHFS class code: 52:32.00.00
Why two NDCs? The FDA registers this code as 0363-0564-53 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00363-0564-53. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name VAPOR INHALER Ingredient Levmetamfetamine
🧪 What is this product?

This is an over-the-counter nasal inhalant decongestant containing levmetamfetamine. It is typically used to relieve nasal congestion by narrowing blood vessels in the nasal passages. The product is marketed under FDA's over-the-counter monograph rules for nasal decongestants rather than through individual product approval. Users inhale the vapor through the nose to help open airways and ease breathing difficulty caused by colds, allergies, or sinus congestion.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1 inhaler
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00363-0564-50 0363-0564-50 Main listing 1 INHALER in 1 BLISTER PACK / 198 INHALANT in 1 INHALER 2016-07-01 — Active
00363-0564-53 You're viewing this 3 INHALER in 1 BLISTER PACK / 198 INHALANT in 1 INHALER 2016-07-01 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 3 inhaler in 1 blister pack / 198 inhalant in 1 inhaler.
What NDC number is used to bill for this package of Vapor Inhaler Levmetamfetamine Nasal Decongestant 50 mg Inhalant?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Vapor Inhaler 50 mg 63868-0267-01 C.D.M.A., 1 inhaler — — FDA listed —
Vapor Inhaler 50 mgthis 00363-0564-53 Walgreens 3 inhalers — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Jul 2016
📍
2026
Currently FDA-listed
10 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerWalgreens
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code00363
First marketedJul 2016
Product typeHuman Otc Drug
Portfolio342 products on file

More NDCs from Walgreens labeler code 00363

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 18 words ▾

Use for temporary relief of nasal congestion due to: the common cold hay fever or upper respiratory allergies

⏱️ Dosage and Administration 73 words ▾

Directions the product delivers in each 800 ml of air 0.04 to 0.150 mg of levmetamfetamine do not use more often than every 2 hours adults and children 12 years of age and over 2 inhalations in each nostril children 6 to under 12 years of age (with adult supervision) 1 inhalation in each nostril children under 6 years of age ask a doctor children under 2 years of age do not use

⚠️ Warnings 94 words ▾

Warnings When using this product do not exceed recommended dosage temporary burning, stinging, sneezing, or increased nasal discharge may occur use of this container by more than one person may spread infection do not use for more than 7 days use only as directed frequent or prolonged use may cause nasal congestion to recur or worsen Stop use and ask a doctor if symptoms persist If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 7 words ▾

Active ingredient (per inhaler) Levmetamfetamine 50 mg

🧪 Inactive Ingredients 10 words ▾

Inactive ingredients bornyl acetate, camphor, lavender oil, menthol, methyl salicylate

🎯 Purpose 3 words ▾

Purpose Nasal decongestant

📄 Do Not Use 24 words ▾

do not use for more than 7 days use only as directed frequent or prolonged use may cause nasal congestion to recur or worsen

📄 When Using This Product 31 words ▾

When using this product do not exceed recommended dosage temporary burning, stinging, sneezing, or increased nasal discharge may occur use of this container by more than one person may spread infection

📄 Stop Use and Ask a Doctor If 9 words ▾

Stop use and ask a doctor if symptoms persist

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 25 words ▾

Other information this inhaler is effective for a minimum of 3 months after first use keep inhaler tightly closed store at 59°-86° F (15°-30° C)

📄 Questions or Comments 5 words ▾

Questions or comments? 1-800-walgreens (1-800-925-4733)

📄 Package Label / Principal Display Panel 52 words ▾

Principal Display Panel – 3 Inhaler Carton VALUE SIZE NDC 0363-0564-53 Contains 3 of NDC 0363-0564-50 Walgreens WALGREENS PHARMACIST RECOMMENDED Vapor Inhaler LEVMETAMFETAMINE / NASAL DECONGESTANT Nasal Decongestant NET WT 0.007 OZ (198 mg) PER INHALER TOTAL NET WT 0.021 0Z (594 mg) 3 INHALERS Principal Display Panel – 3 Inhaler Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Vapor Inhaler (this brand).

Top reported reactions

Dizziness1
Dry Eye1
Eye Pain1
Eye Swelling1
Tachycardia1
Vision Blurred1

Reporter sex

2 reports
Female · 100%
Reports over time (by year) — tap or hover for the count & year
2025 2026 1 1
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Walgreens. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 inhaler (00363-0564-50). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Walgreens is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00363-0563-06 · Walgreen 00363-0566-34 · Walgreen →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.